已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

过敏性肺炎 医学 特发性肺纤维化 比例危险模型 内科学 危险系数 生存分析 肺纤维化 胃肠病学 间质性肺病 肺炎 存活率 纤维化 置信区间
作者
María Laura Alberti,Jose María Malet Ruiz,Martín Tejedor Fernández,Leandro Fassola,Fabían Caro,Ivette Buendía-Roldán,Francisco Paulín
出处
期刊:Pulmonology [Elsevier BV]
卷期号:26 (1): 3-9 被引量:17
标识
DOI:10.1016/j.pulmoe.2019.08.007
摘要

Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease with limited treatment response and bad prognosis. Sometimes it is indistinguishable from idiopathic pulmonary fibrosis (IPF) becoming one of the main differential diagnosis. The aim of our study is to compare survival and functional decline between these two entities.Survival and functional decline more than 10% in FVC were compared using Kaplan Meier (KM) method between patients with CHP and IPF. Cox proportional hazard analysis was used to identify independent predictors of survival and functional decline.146 patients were included, 54 with CHP and 92 with IPF. KM rate for 2 years survival was 0.71 (CI 95% 0,6-0,8) for CHP group and 0,83 (CI 95% 0,66 - 0,92) for IPF (p=0,027). Nevertheless this difference disappeared using Cox proportional hazard analysis, the adjusted HR for survival among CHP patients was 0,53 (CI 95% 0,25-1,15) (p=0,11). There was no difference in functional evolution between the two groups. KM rate for a decline more than or equal to 10% was 0,64 for CHP (CI 95% 0,43-0,79) and 0,78 for IPF (IC 95% 0,6-0,88) (p=0,22). This observation did not change after using Cox proportional hazard analysis.Our study shows that both IPF and CHP are fibrosing interstitial diseases with a similar evolution and survival. It might be possible that therapeutic approach in patients with CHP should change in the light of these observations.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
zhangc发布了新的文献求助20
刚刚
wnflyp完成签到,获得积分10
1秒前
2秒前
碧蓝的以云完成签到,获得积分10
2秒前
Xu完成签到,获得积分10
6秒前
mmol发布了新的文献求助10
8秒前
小马甲应助着诺采纳,获得10
10秒前
11秒前
CodeCraft应助ava采纳,获得10
16秒前
18秒前
18秒前
20秒前
研友_VZG7GZ应助科研通管家采纳,获得10
21秒前
斯文败类应助科研通管家采纳,获得10
21秒前
科研通AI2S应助科研通管家采纳,获得10
21秒前
21秒前
852应助科研通管家采纳,获得10
21秒前
21秒前
爆米花应助科研通管家采纳,获得10
21秒前
无极微光应助科研通管家采纳,获得20
21秒前
molihuakai应助科研通管家采纳,获得10
21秒前
完美世界应助科研通管家采纳,获得10
22秒前
22秒前
22秒前
契约发布了新的文献求助10
23秒前
26秒前
LG发布了新的文献求助10
26秒前
Ava应助辛勤的博涛采纳,获得10
27秒前
甜蜜豁发布了新的文献求助10
28秒前
FashionBoy应助Jonathan采纳,获得10
31秒前
ulani发布了新的文献求助10
34秒前
36秒前
wyy完成签到 ,获得积分10
39秒前
guochang发布了新的文献求助10
41秒前
Ava应助苏素肃采纳,获得10
42秒前
15完成签到,获得积分10
43秒前
XQQDD举报de求助涉嫌违规
43秒前
43秒前
bai完成签到 ,获得积分10
46秒前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
The Immune System (Fifth Edition) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6568941
求助须知:如何正确求助?哪些是违规求助? 8348296
关于积分的说明 17885960
捐赠科研通 5696554
什么是DOI,文献DOI怎么找? 2944317
邀请新用户注册赠送积分活动 1920252
关于科研通互助平台的介绍 1796662